Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Use of postmenopausal hormone therapy since the Women's Health Initiative findings.

Kelly JP, Kaufman DW, Rosenberg L, Kelley K, Cooper SG, Mitchell AA.

Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):837-42.

PMID:
15812877
2.
3.

The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).

Barber CA, Margolis K, Luepker RV, Arnett DK.

J Womens Health (Larchmt). 2004 Nov;13(9):975-85.

PMID:
15665654
4.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
5.

Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.

Du Y, Scheidt-Nave C, Schaffrath Rosario A, Ellert U, Dören M, Knopf H.

Climacteric. 2009 Aug;12(4):329-40. doi: 10.1080/13697130902745120.

PMID:
19437194
6.

Menopausal symptoms after cessation of hormone replacement therapy.

Ness J, Aronow WS, Beck G.

Maturitas. 2006 Feb 20;53(3):356-61.

PMID:
16051451
7.

Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.

Clanget C, Hinke V, Lange S, Fricke R, Botko R, Pfeilschifter J.

Exp Clin Endocrinol Diabetes. 2005 Oct;113(9):529-33.

PMID:
16235155
8.

Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.

Harman SM, Naftolin F, Brinton EA, Judelson DR.

Ann N Y Acad Sci. 2005 Jun;1052:43-56.

PMID:
16024750
9.

Hormone use and patient concerns after the findings of the Women's Health Initiative.

Rolnick SJ, Kopher RA, DeFor TA, Kelley ME.

Menopause. 2005 Jul-Aug;12(4):399-404.

PMID:
16037754
10.

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS; Women's Health Initiative Mammogram Density Study Investigators..

J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76.

11.

After the Women's Health Initiative: decision making and trust of women taking hormone therapy.

Schonberg MA, Davis RB, Wee CC.

Womens Health Issues. 2005 Jul-Aug;15(4):187-95.

PMID:
16051110
12.
13.

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.

Maturitas. 2006 Sep 20;55(2):103-15.

PMID:
16815651
14.

Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.

Ness J, Aronow WS, Newkirk E, McDanel D.

J Gerontol A Biol Sci Med Sci. 2005 Apr;60(4):460-2.

PMID:
15933383
15.

Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.

Rigby AJ, Ma J, Stafford RS.

Menopause. 2007 Sep-Oct;14(5):853-8.

PMID:
17429334
16.

Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.

Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.

Menopause. 2006 Jan-Feb;13(1):125-9.

PMID:
16607108
17.
18.

Recent reversal of trends in hormone therapy use in a European population.

Morabia A, Costanza MC.

Menopause. 2006 Jan-Feb;13(1):111-5.

PMID:
16607106
20.

Correlates of postmenopausal female hormone use among black women in the United States.

Rosenberg L, Palmer JR, Rao RS, Adams-Campbell LL.

Obstet Gynecol. 1998 Mar;91(3):454-8.

PMID:
9491877
Items per page

Supplemental Content

Support Center